- Organization name
- UDI-DI code
- Reference / catalog number
PL-MF-000004770DD 60147392 0001REVO FC 130 is an MDD-legacy medical device registered in EUDAMED. It is classified as Class IIa. Manufactured by OPTOPOL Technology Sp. z o.o.. Placed on the EU market in Sweden. Explore certificates, regulatory status and the EUDAMED record on MD Atlas.
EUDAMED last updated this device on Jun 24, 2022
B-05903293141328Primary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
(01)05903293141328
2 warnings recorded — scroll inside the panel to see all entries.
Sterile
A sterile device is supplied free of viable micro-organisms — flagged so that it is handled, stored and used to preserve that sterile state.
Single-use device
A single-use device is intended to be used on one patient during a single procedure and then discarded — not reprocessed or reused.
Contains latex
A "contains latex" flag warns that a device contains natural rubber latex, which can trigger allergic reactions in sensitive patients.
CMR substance
A CMR flag warns that a device contains a substance that is carcinogenic, mutagenic or toxic to reproduction above a defined threshold.
Endocrine-disrupting substance
An endocrine-disruptor flag warns that a device contains a substance with endocrine-disrupting properties above a defined threshold.
Primary placement in Sweden; available across 24 countries total.
| Country | On market since | Until |
|---|---|---|
| SwedenPrimary placement | Oct 26, 2021 | Still on market |
| Austria | — | Still on market |
| Belgium | — | Still on market |
| Bulgaria | — | Still on market |
| Czechia | — | Still on market |
| Germany | — | Still on market |
| Denmark | May 19, 2022 | Still on market |
| Estonia | — | Still on market |
| EL | May 12, 2022 | Still on market |
| Spain | — | Still on market |
| Finland | — | Still on market |
| France | Apr 22, 2022 | Still on market |
| Croatia | — | Still on market |
| Hungary | — | Still on market |
| Italy | May 19, 2022 | Still on market |
| Lithuania | — | Still on market |
| Latvia | — | Still on market |
| Netherlands | — | Still on market |
| Poland | Mar 28, 2022 | Still on market |
| Portugal | — | Still on market |
| Romania | — | Still on market |
| Slovenia | — | Still on market |
| Slovakia | — | Still on market |
| Türkiye | — | Still on market |
Primary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
05903293141328Basic UDI-DI
The Basic UDI-DI is the main identifier that groups together all device variants of the same model — the regulatory "family" key.
B-05903293141328REF 193-130UDI issuing entities
Issuing entities are the organisations the European Commission has designated to assign Unique Device Identifiers under the EU's UDI system.
MDR risk classes
MDR risk classes rank medical devices from lowest risk (Class I) to highest (Class III), which determines how much regulatory scrutiny they face.
European Medical Device Nomenclature — the EU product classification assigned to this device.
Z12120121OPTICAL CONSISTENCY TOMOGRAPHSNo certificate specifically references this device's Basic UDI-DI.
Certificate health across this manufacturer's portfolio.
DZ 1497914-1IssuedNotified body
A notified body is an independent organisation, designated by an EU country, that audits manufacturers and certifies higher-risk devices before they can be CE-marked.
View in glossary →